Condition
Advanced Malignant Mesothelioma|Epithelial Mesothelioma|Recurrent Malignant Mesothelioma|Sarcomatous Mesothelioma
Estimated Enrollment: 0
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: E1B09|NCI-2011-02068|U10CA021115|CDR0000670445
Study First Received: April 15, 2010
Last Updated: August 1, 2013
Estimated Primary Completion Date: May 2011
Primary Outcome Measures:
Progression-free survival|Toxicity defined as a grade 4 hemorrhagic event or a grade 5 event
Sponsors and Collaborators:
National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT01105390
